Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 1,247 All time
- Disclosed funding
- $110B 713 disclosed amounts
- Median round
- $10.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| TC Tablet CommandCompany profile Incident command software that helps fire and emergency-response agencies coordinate crews, resources and assignments on a shared live map. Incident command software that helps fire and emergency-response agencies coordinate crews, resources and assignments on a shared live map. | Undisclosed | InvestmentUndisclosed | Enterprise software | United States | Investors | |
| R RebuildCompany profile Workflow software for property-restoration contractors that automates estimates, insurance-claim work and project administration. Workflow software for property-restoration contractors that automates estimates, insurance-claim work and project administration. | >$13M | FundingUndisclosed | Proptech | United States | Investors | |
| E EZOCompany profile EZO builds and operates electric vehicle charging networks for local authorities, businesses, fleet operators and drivers. EZO builds and operates electric vehicle charging networks for local authorities, businesses, fleet operators and drivers. | €150M | Senior debt facilityUndisclosed | Mobility | Ireland | Investors | |
| O OpioCompany profile Financial due-diligence software that prepares transaction-services teams’ first analyses from deal data rooms and ledgers. Financial due-diligence software that prepares transaction-services teams’ first analyses from deal data rooms and ledgers. | €4M | Funding roundUndisclosed | Enterprise software | France | Investors | |
| AL Anew LabsCompany profile An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines. An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines. | $290M | FundingUndisclosed | Biotech | China | Investors | |
| P PhosphoenixCompany profile Phosphoenix is developing a brain implant that aims to restore functional vision for people whose blindness cannot be treated through the eyes or optic nerve. Phosphoenix is developing a brain implant that aims to restore functional vision for people whose blindness cannot be treated through the eyes or optic nerve. | €1.3M | Financing roundUndisclosed | Healthtech | Netherlands | Investors | |
| MD MediPro DirectCompany profile MediPro Direct coordinates mobile specimen collection, health screenings and paramedical exams through a nationwide network of vetted medical professionals. Its case-management portal handles ordering, scheduling, tracking and reporting, while a provider-rating system and examiner app help standardize service quality across patient visits and clinical or insurance workflows. MediPro Direct coordinates mobile specimen collection, health screenings and paramedical exams through a nationwide network of vetted medical professionals. Its case-management portal handles ordering, scheduling, tracking and reporting, while a provider-rating system and examiner app help standardize service quality across patient visits and clinical or insurance workflows. | Undisclosed | InvestmentUndisclosed | Healthtech | United States | Investors | |
| E ETFbookCompany profile ETFbook standardises exchange-traded fund data and analytics for financial institutions through a web platform, API and custom feeds. ETFbook standardises exchange-traded fund data and analytics for financial institutions through a web platform, API and custom feeds. | $13M | Funding roundUndisclosed | Fintech | Switzerland | Investors | |
| C ChemifyCompany profile Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds. Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds. | £22M | £22 million grant packageUndisclosed | Industrial tech | United Kingdom | Investors | |
| PL Permian LabsCompany profile Permian Labs develops USD.AI, a credit protocol that finances AI infrastructure. The protocol issues USDai and yield-bearing sUSDai, then connects depositor liquidity to loans secured by GPU assets so compute operators can fund hardware deployments and capital providers can access exposure to those loans; it is operating with infrastructure-financing partners. Permian Labs develops USD.AI, a credit protocol that finances AI infrastructure. The protocol issues USDai and yield-bearing sUSDai, then connects depositor liquidity to loans secured by GPU assets so compute operators can fund hardware deployments and capital providers can access exposure to those loans; it is operating with infrastructure-financing partners. | $40M | Stablecoin-based revolving debt facilityUndisclosed | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
18rounds0led - 2NVIDIA
Riverlane, Foresight, Hiverge
14rounds0led - 3Accel
Coast, Origin, Scimplify
12rounds3led - 4Andreessen Horowitz (a16z)
Conway Research, EliseAI, Thatch
12rounds2led - 5Innovate UK
Emerald, Go Eve, Adaptavate
10rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.